首页> 外文期刊>Journal of Hainan Medical University >Effects of pidotimod combined with dermatophagoides farinae drops on the immune inflammatory response of children with allergic rhinitis complicated by asthma
【24h】

Effects of pidotimod combined with dermatophagoides farinae drops on the immune inflammatory response of children with allergic rhinitis complicated by asthma

机译:匹多莫德联合粉刺皮肤癣菌滴剂对过敏性鼻炎并发哮喘儿童免疫炎症反应的影响

获取原文
           

摘要

Objective: To investigate the effects of pidotimod combined with dermatophagoides farinae drops on the immune inflammatory response of children with allergic rhinitis complicated by asthma. Methods: A total of 142 children with allergic rhinitis complicated by asthma who were treated in this hospital between March 2014 and January 2017 were selected and divided into the control group (n=71) and study group (n=71) by random number table method. Control group were treated with dermatophagoides farinae drops, and study group received pidotimod combined with dermatophagoides farinae drops therapy. The differences in serum contents of immunoglobulin and inflammatory cytokines were compared between two groups of children before treatment and after 1 month of treatment. Results: There was no statistically significant difference in serum contents of immunoglobulin, Th1/Th2 cytokines and Th17/Treg cytokines between the two groups before treatment. After 1 month of treatment, serum sIgE content was lower than that of control group whereas sIgG4 content was higher than that of control group; serum Th1 cytokines IFN-γ and IL-2 contents were higher than those of control group whereas Th2 cytokines IL-4 and IL-5 contents were lower than those of control group; serum Th17 cytokine IL-17 content was lower than that of control group whereas Treg cytokine IL- 10 content was higher than that of control group. Conclusion: Pidotimod combined with dermatophagoides farinae drops can effectively optimize the immune function and suppress the systemic inflammatory response in children with allergic rhinitis complicated by asthma.
机译:目的:探讨吡吡莫德联合法尼通皮滴眼液对过敏性鼻炎并发哮喘儿童免疫炎症反应的影响。方法:选择2014年3月至2017年1月期间在本院接受治疗的142例过敏性鼻炎并发哮喘的儿童,按随机数字表分为对照组(n = 71)和研究组(n = 71)。方法。对照组采用法氏皮肤癣菌滴剂治疗,研究组接受吡莫莫德联合法氏皮肤癣菌滴剂治疗。比较两组患儿治疗前和治疗1个月后血清免疫球蛋白和炎性细胞因子的差异。结果:治疗前两组之间的血清免疫球蛋白,Th1 / Th2细胞因子和Th17 / Treg细胞因子含量无统计学差异。治疗1个月后,血清sIgE含量低于对照组,而sIgG4含量高于对照组。血清Th1细胞因子IFN-γ和IL-2含量高于对照组,而Th2细胞因子IL-4和IL-5含量低于对照组。血清Th17细胞因子IL-17含量低于对照组,而Treg细胞因子IL-10含量高于对照组。结论:吡多莫德联合粉尘皮肤癣菌滴剂可有效优化儿童过敏性鼻炎并发哮喘的免疫功能,并抑制其全身炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号